AIIMS Delhi to start second dose trial of Bharat Biotech’s Covaxin on 2-6 years old children by next week
All India Institute of Medical Sciences (AIIMS) in New Delhi will commence the second dose trial…
All India Institute of Medical Sciences (AIIMS) in New Delhi will commence the second dose trial…
Phase-III trials of Covaxin, made by Hyderabad’s Bharat Biotech, showed it was 93.4% effective against severe…